Company Badge
USPTO Data Jan 1 1976 - Oct 6 2026
5 Patents
#1 in Illkirch Graffenstaden
#2,863 in France
Domain Therapeutics
Forward Citations = 13
9 inventors:
Illkirch Graffenstaden, France
Domain Therapeutics
% Expired Patents = 40.0
CIPO Patents = 4
EPO Patents = 5
Trademarks = 8
Forward Citations = 13
Loading Chart...
Loading Chart...
9 inventors (with patents filed for the assignee):
Stephan Schann (5 out of 10 patents)
Stanislas Mayer (5 out of 9 patents)
Baptiste Manteau (4 out of 6 patents)
4. Anne-Laure Blayo (2 out of 2 patents)
5. Thomas Catelain (1 out of 1 patent)
6. Ismet Dorange (1 out of 1 patent)
7. Cédric Genet (1 out of 1 patent)
8. Ismet Dorange (1 out of 1 patent)
9. Gaël Hommet (1 out of 1 patent)
10. Bruno Giethlen (23 patents)
11. Mireille Hogue (2 patents)
12. Christian Le Gouill (2 patents)
13. Viktoriya Lukasheva (2 patents)
14. Michel Bouvier (13 patents)
15. Christophe Morice (10 patents)
5 patents:
Domain Therapeutics is a biopharmaceutical company specializing in G protein-coupled receptors (GPCRs) drug discovery. They develop innovative treatments for neurological, oncological, and rare diseases by leveraging their expertise in discovering and modulating GPCR targets. With a focus on precision medicine and personalized therapies, Domain Therapeutics aims to improve patient outcomes and address unmet medical needs in a variety of therapeutic areas.
Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
4 patents (CIPO):
Please report any incorrect information to [email protected]
5 patents (EPO):
Please report any incorrect information to [email protected]